HUP1100445A2 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- HUP1100445A2 HUP1100445A2 HU1100445A HUP1100445A HUP1100445A2 HU P1100445 A2 HUP1100445 A2 HU P1100445A2 HU 1100445 A HU1100445 A HU 1100445A HU P1100445 A HUP1100445 A HU P1100445A HU P1100445 A2 HUP1100445 A2 HU P1100445A2
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1100445A HUP1100445A2 (en) | 2011-08-17 | 2011-08-17 | Pharmaceutical composition |
PCT/HU2012/000071 WO2013024312A1 (en) | 2011-08-17 | 2012-08-14 | A pharmaceutical composition for the treatment of stem cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1100445A HUP1100445A2 (en) | 2011-08-17 | 2011-08-17 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP1100445A2 true HUP1100445A2 (en) | 2013-02-28 |
Family
ID=89990396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU1100445A HUP1100445A2 (en) | 2011-08-17 | 2011-08-17 | Pharmaceutical composition |
Country Status (2)
Country | Link |
---|---|
HU (1) | HUP1100445A2 (en) |
WO (1) | WO2013024312A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP1800298A1 (en) | 2018-08-30 | 2020-05-28 | N Gene Res Laboratories Inc | Combination of beta blocker and hydroximic acid derivative with reduced side effects |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4187220A (en) | 1977-08-30 | 1980-02-05 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
HU9502843D0 (en) | 1995-09-29 | 1995-11-28 | Livigene Ltd | Pharmaceutical composition |
US6458371B1 (en) | 1995-12-22 | 2002-10-01 | Medgene, Limited | Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin |
US6884424B2 (en) | 1995-12-22 | 2005-04-26 | N-Gene Research Laboratories Inc. | Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight |
HUP9701080A3 (en) | 1997-06-23 | 1999-05-28 | Gene Res Lab Inc New York N | Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative |
HU9701081D0 (en) * | 1997-06-23 | 1997-08-28 | Gene Research Lab Inc N | Pharmaceutical composition of antitumoral activity |
AU5296799A (en) | 1998-08-03 | 2000-02-28 | N-Gene Kutato Kft. | Pharmaceutical compositions against autoimmune diseases |
PL358393A1 (en) | 2000-03-20 | 2004-08-09 | N-Gene Research Laboratories Inc. | Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
CN1270713C (en) | 2001-07-17 | 2006-08-23 | N基因研究实验室公司 | Synergistic pharmaceutical combination for prevention or treatment of diabetes |
HUP0401177A2 (en) | 2004-06-14 | 2007-09-28 | N Gene Res Lab Inc | Pharmaceutical composition for increasing the mitochondrial genesis |
HUP0401176A2 (en) | 2004-06-14 | 2007-09-28 | N Gene Res Lab Inc | Pharmaceutical composition having prpkinetic effect |
HUP0500145A2 (en) | 2005-01-28 | 2006-11-28 | Gene Res Lab N | Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases |
US20080108602A1 (en) | 2006-11-02 | 2008-05-08 | N-Gene Research Laboratories, Inc. | Prevention of obesity in antipsychotic, antidepressant and antiepileptic medication |
US7763601B2 (en) | 2006-11-02 | 2010-07-27 | N-Gene Research Laboratories, Inc. | Prevention and treatment of obesity |
US20090281143A1 (en) | 2007-12-10 | 2009-11-12 | N-Gene Research Laboratories, Inc. | Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or Obesity |
US20100137976A1 (en) * | 2008-12-02 | 2010-06-03 | Medtronic Vascular, Inc. | Systems and Methods for Treating Heart Tissue Via Localized Delivery of Parp Inhibitors |
-
2011
- 2011-08-17 HU HU1100445A patent/HUP1100445A2/en unknown
-
2012
- 2012-08-14 WO PCT/HU2012/000071 patent/WO2013024312A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2013024312A1 (en) | 2013-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP3864A (en) | Pharmaceutical composition | |
GB201113662D0 (en) | Pharmaceutical compositions | |
ZA201308208B (en) | Pharmaceutical compositions | |
HK1199824A1 (en) | Pharmaceutical compositions | |
ZA201501930B (en) | Pharmaceutical composition | |
GB201118232D0 (en) | Pharmaceutical composition | |
EP2832730A4 (en) | Mirabegron-containing pharmaceutical composition | |
EP2702989A4 (en) | Stable pharmaceutical composition | |
HK1189158A1 (en) | Pharmaceutical composition | |
EP2769718A4 (en) | Medicinal composition | |
EP2731610A4 (en) | Pharmaceutical combination | |
GB201106520D0 (en) | Pharmaceutical compounds | |
GB201118181D0 (en) | Pharmaceutical compositions | |
EP2727593A4 (en) | Nicorandil-containing pharmaceutical composition | |
EP2711010A4 (en) | Pharmaceutical composition | |
HUP1100444A2 (en) | Pharmaceutical composition | |
ZA201502987B (en) | Pharmaceutical composition | |
ZA201308414B (en) | Solid pharmaceutical composition | |
EP2897590A4 (en) | Pharmaceutical composition | |
HUP1100445A2 (en) | Pharmaceutical composition | |
EP2714715A4 (en) | Pharmaceutical compositions | |
EP2851078A4 (en) | Pharmaceutical composition | |
ZA201309537B (en) | Pharmaceutical composition comprising fexofedine | |
EP2727594A4 (en) | Novel pharmaceutical composition | |
ZA201400751B (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees | ||
GB9A | Succession in title |
Owner name: PHARMA-GENE SA, CH Free format text: FORMER OWNER(S): DR. HAZAY BALAZS, HU |